Membrane Span Kinase Fusion for GPCR Interaction Detection
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for detecting protein-protein interactions, particularly involving GPCRs, face limitations such as low sensitivity, false positives, and inability to detect modification-dependent interactions under physiological conditions, and are not suitable for studying integral membrane proteins.
Innovation Solution
A recombinant membrane span protein complex is developed, comprising a fusion protein with a kinase domain and a reporter phosphorylation domain, allowing for increased detection sensitivity and the ability to study interactions under physiological conditions by using a constitutive mutant kinase that can be activated by an exogenous small molecule, enhancing the detection window and enabling the detection of compound-protein interactions.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Adaptability or versatility
If yeast two-hybrid system is used to detect protein-protein interactions, then the method becomes widely applicable, but it causes false positives and cannot detect modification-dependent interactions
Solution Approach 1:
The patent introduces an intermediary kinase domain that acts as a mediator between the membrane span protein and the reporter system. This kinase domain receives phosphorylation signals from the membrane span protein and transmits them to the reporter phosphorylation domain, enabling indirect detection that avoids false positives while maintaining versatility across different protein interactions
Solution Approach 2:
The patent replaces the direct mechanical binding detection of yeast two-hybrid with a biochemical signal transduction system. Instead of relying on direct physical interaction between fusion proteins, the system uses phosphorylation cascades and kinase activity as intermediaries to detect protein-protein interactions, thereby improving reliability through biochemical specificity
2Productivity
If phage display is used to screen binding proteins, then high throughput screening is achieved, but the proteins are exposed to non-physiological environment
Solution Approach 1:
The patent changes the environmental parameters of protein interaction detection by moving from the non-physiological phage surface environment to the physiological plasma membrane environment. This parameter change maintains high throughput capability while restoring physiological relevance through proper membrane localization and native-like interaction conditions
3Reliability
If protein recruitment system is used to detect interactions at plasma membrane, then physiological conditions are maintained, but modification-dependent interactions cannot be detected
Solution Approach 1:
The patent creates a universal detection system that combines the physiological relevance of plasma membrane recruitment with the versatility to detect modification-dependent interactions. The kinase domain serves multiple functions: it detects protein recruitment to the membrane, senses phosphorylation modifications, and transmits signals to reporters, thereby achieving both physiological accuracy and broad detection capability
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The approach significantly enhances the detection sensitivity and specificity of protein-protein interactions, particularly for GPCRs, allowing for the detection of ligand-receptor binding and inhibitor screening with a wider dynamic range and improved physiological relevance.
Implementation Method 1
a fusion protein, comprising a membrane span protein fused to a kinase domain
Data Source
AI summary
The disclosure relates to a recombinant membrane span protein complex, comprising (1) a fusion protein, comprising a membrane span protein fused to a kinase domain, preferably a constitutive kinase and (2) a reporter construct comprising a polypeptide, interacting with the membrane span protein, fused to a reporter phosphorylation domain. The disclosure relates further to the uses of such membrane span protein complex for the detection of compounds that interact with the membrane span protein and for the screening and/or detection of inhibitors of the compound-membrane span protein interactions. In a preferred embodiment, the membrane span protein is a G protein coupled receptor (GPCR) and the method is used for the screening and/or detection of inhibitors of the ligand-receptor binding.